| Literature DB >> 35071941 |
Abstract
The probiotic potential of lactic acid bacteria (LAB) isolated from Thai traditional fermented food was investigated. Forty-two samples were collected from four markets in Phra Nakhon Si Ayutthaya Province. Out of 50 isolated LAB, 6 (a3, f4, f8, K1, K4 and K9) obtained from pla-ra and bamboo shoot pickle samples showed high tolerance to gastrointestinal tract conditions. These isolates were selected to identify and characterize their probiotic properties. Isolate a3 was identified as Weissella thailandensis, isolates f4 and f8 were identified as belonging to Enterococcus thailandicus and isolates K1, K4 and K9 were determined as Limosilactobacillus fermentum. All six LAB exhibited high autoaggregation ability (93.40-95.01%), while W. thailandensis isolate a3 showed potential for coaggregation in almost all the pathogenic bacteria tested. Cell-free supernatant (CFS) obtained from all isolates did not inhibit Staphylococcus aureus. CFS derived from L. fermentum isolate K4 showed the most efficient antimicrobial activity, in particular against Gram-negative bacteria, while L. fermentum isolate K4 presented high surface hydrophobicity in the presence of xylene and n-hexane. All LAB isolates were found to be resistant to clindamycin and nalidixic acid, whereas E. thailandicus isolate f8 exhibited resistance to most of the antibiotics tested. L. fermentum isolate K4 showed promise as a suitable probiotic candidate for future applications in the food industry due to tolerance to gastrointestinal tract conditions with high surface hydrophobicity and inhibited most of the pathogens tested.Entities:
Keywords: Phra Nakhon Si Ayutthaya; Thai traditional fermented food; lactic acid bacteria; probiotic bacteria; probiotic properties
Year: 2021 PMID: 35071941 PMCID: PMC8712534 DOI: 10.3934/microbiol.2021026
Source DB: PubMed Journal: AIMS Microbiol ISSN: 2471-1888
Isolation of LAB from Thai tradition fermented food in Phra Nakhon Si Ayutthaya Province.
| Market | Fermented food | Samples | Number | Isolates |
| Grand | Phak-gard-dorng | 3 | 0 | |
| Bamboo shoots pickles | 2 | 0 | ||
| Pla-ra | 3 | 5 | H1, H2, H3, H4, H6 | |
|
| ||||
| Chao Phrom | Phak-gard-dorng | 4 | 3 | S2, S4, S6 |
| Bamboo shoots pickles | 4 | 13 | K1, K2, K4, K5, K6, K8, K9, K10, L1, Q1, Q2, Q4, Q6 | |
| Pla-ra | 3 | 6 | N4, N5, O5, P1, P3, P5 | |
|
| ||||
| DD | Phak-gard-dorng | 3 | 0 | |
| Bamboo shoots pickles | 3 | 0 | ||
| Ginger pickles | 1 | 0 | ||
| Pla-ra | 5 | 10 | a3, b6, f1, f3, f4, f6, f7, f8, f9, f10 | |
|
| ||||
| 4 Right Development | Phak-gard-dorng | 3 | 0 | |
| Bamboo shoots pickles | 3 | 6 | k1, m1, m2, m3, m4, m5 | |
| Ginger pickles | 1 | 0 | ||
| Pla-ra | 3 | 5 | q2, t1, t2, t4, t5 | |
| Thai fermented pork sausage (Sai-krog-prieo) | 1 | 2 | x1, x2 | |
|
| ||||
| Total | 42 | 50 | ||
Tolerance to simulated gastric juice and bile salt of LAB isolates
| Isolate | Tolerance to gastric juice (%) | Tolerance to bile salt (%) | Isolate | Tolerance to gastric juice (%) | Tolerance to bile salt (%) |
| a3 | 78.47 ± 0.13 | 93.31 ± 0.32 | m2 | 14.30 ± 0.14 | 97.87 ± 0.84 |
| b6 | 13.84 ± 0.79 | 79.87 ± 0.58 | m3 | 49.09 ± 0.08 | 99.87 ± 0.56 |
| f1 | 70.90 ± 0.06 | 98.15 ± 1.17 | m4 | 41.78 ± 2.18 | 86.65 ± 0.33 |
| f3 | 64.33 ± 0.93 | 78.68 ± 0.13 | m5 | 12.13 ± 0.46 | 99.44 ± 1.25 |
| f4 | 93.01 ± 0.12 | 91.63 ± 1.84 | N4 | 12.33 ± 1.56 | 99.84 ± 0.00 |
| f6 | 54.51 ± 0.31 | 85.75 ± 0.02 | N5 | 11.56 ± 0.78 | 95.36 ± 1.77 |
| f7 | 73.61 ± 0.03 | 89.62 ± 0.89 | O5 | 50.58 ± 0.44 | 93.51 ± 0.82 |
| f8 | 83.42 ± 0.76 | 93.70 ± 0.35 | P1 | 11.10 ± 0.16 | 91.09±1.68 |
| f9 | 40.85 ± 1.64 | 94.46 ± 0.40 | P3 | 55.89 ± 0.23 | 90.41 ± 1.24 |
| f10 | 57.29 ± 0.16 | 99.19 ± 0.09 | P5 | 10.92 ± 0.16 | 83.71 ± 2.18 |
| H1 | 63.73 ± 1.02 | 89.98 ± 0.93 | Q1 | 74.34 ± 0.32 | 93.78 ± 1.32 |
| H2 | 46.78 ± 0.41 | 99.48 ± 0.33 | Q2 | 70.42 ± 0.30 | 94.42 ± 2.12 |
| H3 | 56.41 ± 1.59 | 91.91 ± 1.48 | Q4 | 65.72 ± 0.66 | 99.13 ± 0.14 |
| H4 | 63.75 ± 0.04 | 64.39 ± 1.72 | Q6 | 69.69 ± 0.03 | 99.58 ± 0.27 |
| H6 | 72.97 ± 0.42 | 55.43 ± 0.97 | S2 | 9.21 ± 2.11 | 48.51 ± 2.49 |
| K1 | 81.85 ± 0.25 | 95.21 ± 2.31 | S4 | 11.48 ± 0.16 | 71.07 ± 0.87 |
| K2 | 12.98 ± 0.35 | 95.93 ± 0.46 | S6 | 10.25 ± 2.12 | 97.38 ± 0.18 |
| K4 | 90.75 ± 0.05 | 94.62 ± 2.80 | t1 | 44.32 ± 0.95 | 83.97 ± 0.42 |
| K5 | 70.09 ± 0.19 | 55.11 ± 2.83 | t2 | 11.52 ± 0.31 | 75.13 ± 1.31 |
| K6 | 54.03 ± 0.56 | 67.32 ± 6.21 | t4 | 43.96 ± 0.19 | 55.21 ± 3.22 |
| K9 | 78.50 ± 0.06 | 89.94 ± 1.73 | t5 | 42.18 ± 0.23 | 57.82 ± 2.12 |
| K8 | 55.41 ± 0.33 | 19.63 ± 2.25 | x1 | 49.70 ± 0.10 | 77.34 ± 1.22 |
| K10 | 54.83 ± 0.07 | 98.88 ± 1.81 | x2 | 46.88 ± 0.58 | 79.08 ± 0.56 |
| L1 | 10.87 ± 0.16 | 96.39 ± 0.48 | k1 | 10.21 ± 3.12 | 94.08 ± 0.67 |
| m1 | 13.94 ± 0.18 | 83.39 ± 0.18 | q2 | 9.23 ± 0.93 | 63.15 ± 3.95 |
Identification of LAB with high tolerance in simulated gastric juice and bile salt.
| Isolates | Genus | Identities (%) | GenBank ID of reference strain | Accession number |
| a3 |
| 99 | LC097077.1 | MZ577177 |
| f4 |
| 99 | LT223669.1 | MZ577179 |
| f8 |
| 100 | LT223669.1 | MZ577180 |
| K1 |
| 99 | MK418588.1 | MZ577182 |
| K4 |
| 100 | MN589591.1 | MZ577208 |
| K9 |
| 100 | MN589591.1 | MZ577210 |
Autoaggregation and coaggregation ability of LAB isolates against pathogenic bacteria.
| Isolate | Autoaggregation (%) | Coaggregation (%) | |||||||
|
|
|
|
|
|
|
| |||
| a3 | 95.00 ± 0.09* | 11.73 ± 1.84Ba | 38.50 ± 0.45Aa | 14.36 ± 4.48Ba | 4.95 ± 0.10C* | 3.13 ± 0.39Cc | 10.01 ± 2.92Ba | 12.06 ± 1.14Ba | 2.60 ± 0.41Cd |
| f4 | 94.83 ± 0.30* | 5.13 ± 0.94Cc | 12.94 ± 1.35Acd | 12.13 ± 0.90Aa | 5.86 ± 0.95BC* | 8.08 ± 1.31Ba | 5.46 ± 1.67Cb | 4.97 ± 0.55Cc | 5.73 ± 0.90BCc |
| f8 | 93.40 ± 0.33* | 9.01 ± 0.32Bb | 15.62 ± 2.66Ac | 14.93 ± 3.35Aa | 8.07 ± 1.84B* | 5.72 ± 0.70Babc | 9.11 ± 1.74Bab | 2.24 ± 1.52Cd | 8.25 ± 0.20Bb |
| K1 | 95.01 ± 0.28* | 8.62 ± 0.81ABb | 23.23 ± 3.76Ab | 5.48 ± 1.56Cb | 7.93 ± 1.62BC* | 6.65 ± 0.27BCab | 7.07 ± 1.56BCab | 7.70 ± 0.73BCb | 10.38 ± 0.69Ba |
| K4 | 94.57 ± 0.06* | 7.15 ± 1.17Bbc | 11.83 ± 0.38Acd | 10.74 ± 1.95Aa | 7.44 ± 1.30B* | 4.35 ± 0.87Cbc | 8.05 ± 1.16Bab | 6.11 ± 0.10BCbc | 6.24 ± 0.33BCc |
| K9 | 94.62 ± 0.15* | 5.56 ± 0.74Cc | 10.15 ± 2.07ABd | 12.41 ± 2.17Aa | 7.48 ± 0.17BC* | 5.61 ± 1.81Cabc | 5.76 ± 0.13Cb | 5.69 ± 1.22Cbc | 5.81 ± 0.07Cc |
Lowercase letters indicate significant differences in percentage coaggregation among the 6 isolates against the same pathogenic bacteria (P < 0.05). Capital letters indicate significant differences in percentage coaggregation of each isolate against 8 pathogenic bacteria (P < 0.05).
*indicates no significant difference in percentage autoaggregation or coaggregation (P > 0.05).
Figure 1.Surface hydrophobicity of LAB in the presence of xylene □ and █ n-hexane. Lowercase letters indicate significant differences in surface hydrophobicity percentages among 6 isolates in the presence of xylene or n-hexane (P < 0.05). Capital letters indicate significant differences in surface hydrophobicity percentages of each isolate in the presence of xylene and n-hexane (P < 0.05). *indicates no significant difference in surface hydrophobicity percentage (P > 0.05).
In vitro inhibition of pathogenic bacteria by LAB isolates.
| Isolate | Diameter of inhibition zones (mm) | |||||||
|
|
|
|
|
|
|
| ||
| a3 | 0.00 ± 0.00*d | 0.00 ± 0.00** | 0.00 ± 0.00*b | 0.00 ± 0.00*c | 0.00 ± 0.00*b | 0.00 ± 0.00*b | 0.00 ± 0.00*c | 0.00 ± 0.00*c |
| f4 | 0.00 ± 0.00Bd | 0.00 ± 0.00B* | 0.00 ± 0.00B | 0.00 ± 0.00Bc | 0.00 ± 0.00Bb | 0.00 ± 0.00Bb | 10.00 ± 0.00Aa | 0.00 ± 0.00Bc |
| f8 | 0.00 ± 0.00*d | 0.00 ± 0.00** | 0.00 ± 0.00*b | 0.00 ± 0.00*c | 0.00 ± 0.00*b | 0.00 ± 0.00*b | 0.00 ± 0.00*c | 0.00 ± 0.00*c |
| K1 | 7.50 ± 0.70Ac | 0.00 ± 0.00B* | 0.00 ± 0.00Bb | 0.00 ± 0.00Bc | 0.00 ± 0.00Bb | 0.00 ± 0.00Bb | 0.00 ± 0.00Bc | 0.00 ± 0.00Bc |
| K4 | 9.00 ± 0.00Cb | 0.00 ± 0.00D* | 9.30 ± 0.50Ba | 9.00 ± 0.00Cb | 0.00 ± 0.00Db | 9.00 ± 0.80Ca | 9.00 ± 0.00Cb | 11.00 ± 0.70Aa |
| K9 | 9.90 ± 0.80Ba | 0.00 ± 0.00C* | 0.00 ± 0.00Cb | 10.00 ± 0.00Aa | 10.00 ± 0.00Aa | 0.00 ± 0.00Cb | 0.00 ± 0.00Cc | 10.00 ± 0.00Ab |
| Streptomycin | 16.40 ± 1.50 | 17.00 ± 1.80 | 12.70 ± 0.50 | 21.00 ± 0.00 | 39.00 ± 1.10 | 23.20 ± 3.20 | 16.30 ± 3.70 | 18.70 ± 1.10 |
Lowercase letters indicate significant differences in the diameter of the CFS inhibition zone obtained from the 6 isolates against the same pathogenic bacteria (P < 0.05).
Capital letters indicate significant differences in diameter of the inhibition zone of CFS obtained from each isolate against the 8 pathogenic bacteria (P < 0.05).
*indicates no significant difference in the diameter of the inhibition zone (P > 0.05).
Antibiotic resistant of isolated LAB.
| Isolates | Antibiotic | ||||
| Penicillin | Ampicillin | Amoxicillin | Clindamycin | Nalidixic acid | |
| a3 | R | S | MS | R | R |
| f4 | R | S | MS | R | R |
| f8 | R | MS | R | R | R |
| K1 | MS | S | S | R | R |
| K4 | MS | S | MS | R | R |
| K9 | MS | S | MS | R | R |
Susceptibility is expressed as R (resistant), MS (moderate susceptible) or S (susceptible).